FAK in cancer: mechanistic findings and clinical applications

FJ Sulzmaier, C Jean, DD Schlaepfer - Nature reviews cancer, 2014 - nature.com
Focal adhesion kinase (FAK) is a cytoplasmic protein tyrosine kinase that is overexpressed
and activated in several advanced-stage solid cancers. FAK promotes tumour progression …

[HTML][HTML] MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress

M Felder, A Kapur, J Gonzalez-Bosquet, S Horibata… - Molecular cancer, 2014 - Springer
Over three decades have passed since the first report on the expression of CA125 by
ovarian tumors. Since that time our understanding of ovarian cancer biology has changed …

[HTML][HTML] Integrated genomic characterization of papillary thyroid carcinoma

N Agrawal, R Akbani, BA Aksoy, A Ally, H Arachchi… - Cell, 2014 - cell.com
Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. Here, we
describe the genomic landscape of 496 PTCs. We observed a low frequency of somatic …

[HTML][HTML] Organoid cultures derived from patients with advanced prostate cancer

D Gao, I Vela, A Sboner, PJ Iaquinta, WR Karthaus… - Cell, 2014 - cell.com
The lack of in vitro prostate cancer models that recapitulate the diversity of human prostate
cancer has hampered progress in understanding disease pathogenesis and therapy …

[HTML][HTML] Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin

KA Hoadley, C Yau, DM Wolf, AD Cherniack… - Cell, 2014 - cell.com
Recent genomic analyses of pathologically defined tumor types identify" within-a-tissue"
disease subtypes. However, the extent to which genomic signatures are shared across …

Proteogenomic characterization of human colon and rectal cancer

B Zhang, J Wang, X Wang, J Zhu, Q Liu, Z Shi… - Nature, 2014 - nature.com
Extensive genomic characterization of human cancers presents the problem of inference
from genomic abnormalities to cancer phenotypes. To address this problem, we analysed …

Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in …

J Ledermann, P Harter, C Gourley… - The lancet …, 2014 - thelancet.com
Background Maintenance monotherapy with the PARP inhibitor olaparib significantly
prolonged progression-free survival (PFS) versus placebo in patients with platinum-sensitive …

[HTML][HTML] The landscape of kinase fusions in cancer

N Stransky, E Cerami, S Schalm, JL Kim… - Nature …, 2014 - nature.com
Human cancer genomes harbour a variety of alterations leading to the deregulation of key
pathways in tumour cells. The genomic characterization of tumours has uncovered …

Genetic landscape of esophageal squamous cell carcinoma

YB Gao, ZL Chen, JG Li, XD Hu, XJ Shi, ZM Sun… - Nature …, 2014 - nature.com
Esophageal squamous cell carcinoma (ESCC) is one of the deadliest cancers. We
performed exome sequencing on 113 tumor-normal pairs, yielding a mean of 82 non-silent …

[HTML][HTML] Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy

JG Lohr, P Stojanov, SL Carter, P Cruz-Gordillo… - Cancer cell, 2014 - cell.com
We performed massively parallel sequencing of paired tumor/normal samples from 203
multiple myeloma (MM) patients and identified significantly mutated genes and copy number …